Mandi M. Murph

2.4k total citations
44 papers, 1.9k citations indexed

About

Mandi M. Murph is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Mandi M. Murph has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 14 papers in Cell Biology and 8 papers in Cancer Research. Recurrent topics in Mandi M. Murph's work include Sphingolipid Metabolism and Signaling (20 papers), Endoplasmic Reticulum Stress and Disease (9 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Mandi M. Murph is often cited by papers focused on Sphingolipid Metabolism and Signaling (20 papers), Endoplasmic Reticulum Stress and Disease (9 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Mandi M. Murph collaborates with scholars based in United States, United Kingdom and Japan. Mandi M. Murph's co-authors include Gordon B. Mills, Shuangxing Yu, Yiling Lu, Harish Radhakrishna, Shuying Liu, Shuying Liu, Xianjun Fang, Michael G. Bartlett, Babak Basiri and Molly K. Altman and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Mandi M. Murph

43 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mandi M. Murph United States	23	1.6k	506	281	214	125	44	1.9k
Valeria Bertagnolo Italy	25	1.5k 0.9×	356 0.7×	256 0.9×	345 1.6×	202 1.6×	85	2.0k
Shuangxing Yu United States	27	2.7k 1.7×	639 1.3×	560 2.0×	436 2.0×	311 2.5×	33	3.2k
Gary Bellinger United States	11	1.4k 0.9×	201 0.4×	749 2.7×	360 1.7×	139 1.1×	13	1.9k
Robert T. Dorsam United States	18	1.3k 0.8×	172 0.3×	219 0.8×	432 2.0×	238 1.9×	22	2.6k
Heidi Sankala United States	15	1.6k 1.0×	604 1.2×	176 0.6×	167 0.8×	173 1.4×	28	1.7k
Sahar A. Saddoughi United States	11	1.0k 0.7×	275 0.5×	131 0.5×	129 0.6×	105 0.8×	38	1.4k
Friederike Cuello United Kingdom	27	1.6k 1.0×	134 0.3×	172 0.6×	122 0.6×	134 1.1×	50	2.4k
Dmitri Pchejetski United Kingdom	28	1.9k 1.2×	702 1.4×	314 1.1×	261 1.2×	161 1.3×	54	2.4k
Hiroko Iwanari Japan	18	949 0.6×	305 0.6×	131 0.5×	221 1.0×	271 2.2×	31	1.7k
Makiko Umezu‐Goto United States	9	1.3k 0.8×	483 1.0×	94 0.3×	105 0.5×	127 1.0×	10	1.5k

Countries citing papers authored by Mandi M. Murph

Since Specialization

Citations

This map shows the geographic impact of Mandi M. Murph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandi M. Murph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandi M. Murph more than expected).

Fields of papers citing papers by Mandi M. Murph

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mandi M. Murph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandi M. Murph. The network helps show where Mandi M. Murph may publish in the future.

Co-authorship network of co-authors of Mandi M. Murph

This figure shows the co-authorship network connecting the top 25 collaborators of Mandi M. Murph. A scholar is included among the top collaborators of Mandi M. Murph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mandi M. Murph. Mandi M. Murph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Zhou, Yi, Shannon Quinn, Melissa B. Davis, et al.. (2021). Are we there yet? A machine learning architecture to predict organotropic metastases. BMC Medical Genomics. 14(1). 281–281. 1 indexed citations

2.

Jia, Wei, et al.. (2018). miR-122-5p Expression and Secretion in Melanoma Cells Is Amplified by the LPAR3 SH3–Binding Domain to Regulate Wnt1. Molecular Cancer Research. 17(1). 299–309. 17 indexed citations

3.

Basiri, Babak, et al.. (2018). Direct identification of microribonucleic acid miR-451 from plasma using liquid chromatography mass spectrometry. Journal of Chromatography A. 1584. 97–105. 33 indexed citations

4.

Jia, Wei, Shuying Liu, Há Thi Nguyen, et al.. (2018). Autotaxin exacerbates tumor progression by enhancing MEK1 and overriding the function of miR-489-3p. Cancer Letters. 432. 84–92. 12 indexed citations

5.

Nguyen, Há Thi, Wei Jia, Aaron M. Beedle, Eileen J. Kennedy, & Mandi M. Murph. (2015). Lysophosphatidic Acid Mediates Activating Transcription Factor 3 Expression Which Is a Target for Post-Transcriptional Silencing by miR-30c-2-3p. PLoS ONE. 10(9). e0139489–e0139489. 4 indexed citations

6.

Altman, Molly K., Ali A. Alshamrani, Wei Jia, et al.. (2015). Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells. Cancer Letters. 369(1). 175–183. 22 indexed citations

7.

Jia, Wei, et al.. (2014). The Src homology 3 binding domain is required for lysophosphatidic acid 3 receptor-mediated cellular viability in melanoma cells. Cancer Letters. 356(2). 589–596. 11 indexed citations

8.

Nguyen, Há Thi, Geng Tian, & Mandi M. Murph. (2014). Molecular Epigenetics in the Management of Ovarian Cancer: Are We Investigating a Rational Clinical Promise?. Frontiers in Oncology. 4. 71–71. 18 indexed citations

9.

Jia, Wei, et al.. (2011). MicroRNA-30c-2* Expressed in Ovarian Cancer Cells Suppresses Growth Factor–Induced Cellular Proliferation and Downregulates the Oncogene BCL9. Molecular Cancer Research. 9(12). 1732–1745. 56 indexed citations

10.

Murph, Mandi M., Wenbin Liu, Shuangxing Yu, et al.. (2009). Lysophosphatidic Acid-Induced Transcriptional Profile Represents Serous Epithelial Ovarian Carcinoma and Worsened Prognosis. PLoS ONE. 4(5). e5583–e5583. 53 indexed citations

11.

Liu, Shuying, Makiko Umezu‐Goto, Mandi M. Murph, et al.. (2009). Expression of Autotaxin and Lysophosphatidic Acid Receptors Increases Mammary Tumorigenesis, Invasion, and Metastases. Cancer Cell. 15(6). 539–550. 310 indexed citations

12.

Liu, Shuying, Makiko Umezu‐Goto, Mandi M. Murph, et al.. (2009). Expression of Autotaxin and Lysophosphatidic Acid Receptors Increases Mammary Tumorigenesis, Invasion, and Metastases. Cancer Cell. 16(2). 172–172. 12 indexed citations

13.

Murph, Mandi M.. (2008). Sharpening the edges of understanding the structure/function of the LPA1 receptor: Expression in cancer and mechanisms of regulation☆. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1781(9). 547–557. 41 indexed citations

14.

Hasegawa, Yutaka, Mandi M. Murph, Shuangxing Yu, Gábor Tigyi, & Gordon B. Mills. (2008). Lysophosphatidic acid (LPA)‐induced vasodilator‐stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC‐3 prostate cancer cells. Molecular Oncology. 2(1). 54–69. 35 indexed citations

15.

Hennessy, Bryan T., Mandi M. Murph, Meera Nanjundan, et al.. (2008). Ovarian Cancer: Linking Genomics to New Target Discovery and Molecular Markers — The Way Ahead. Advances in experimental medicine and biology. 617. 23–40. 11 indexed citations

16.

Murph, Mandi M. & Gordon B. Mills. (2007). Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression. Expert Reviews in Molecular Medicine. 9(28). 1–18. 54 indexed citations

17.

Murph, Mandi M., Tamotsu Tanaka, Jihai Pang, et al.. (2007). Liquid Chromatography Mass Spectrometry for Quantifying Plasma Lysophospholipids: Potential Biomarkers for Cancer Diagnosis. Methods in enzymology on CD-ROM/Methods in enzymology. 433. 1–25. 86 indexed citations

18.

Murph, Mandi M., et al.. (2007). Lysophosphatidic Acid Decreases the Nuclear Localization and Cellular Abundance of the p53 Tumor Suppressor in A549 Lung Carcinoma Cells. Molecular Cancer Research. 5(11). 1201–1211. 48 indexed citations

19.

Murph, Mandi M., et al.. (2003). Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway. Journal of Cell Science. 116(10). 1969–1980. 67 indexed citations

20.

Murph, Mandi M., et al.. (2002). Transfer of M2 Muscarinic Acetylcholine Receptors to Clathrin-derived Early Endosomes following Clathrin-independent Endocytosis. Journal of Biological Chemistry. 277(36). 33439–33446. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact